A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia)

NCT03939104 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

103

Enrollment

OTHER

Sponsor class

Conditions

Plasmodium Falciparum Malaria (Uncomplicated)

Interventions

DRUG: Artemether-lumefantrine+amodiaquine
DRUG: Artemether-lumefantrine+placebo
DRUG: Artesunate-mefloquine+piperaquine
DRUG: Artesunate-mefloquine+placebo

Sponsor

University of Oxford

Collaborators

[object Object]